These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35782075)

  • 1. Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy.
    Xu J; Cao W; Shao A; Yang M; Andoh V; Ge Q; Pan HW; Chen KP
    Biomed Res Int; 2022; 2022():7819235. PubMed ID: 35782075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
    Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
    J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
    Cheng J; Zheng G; Jin H; Gao X
    Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.
    Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
    Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.
    Zhao YX; Zhao HP; Zhao MY; Yu Y; Qi X; Wang JH; Lv J
    World J Gastroenterol; 2024 May; 30(20):2638-2656. PubMed ID: 38855150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
    Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
    Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
    Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
    J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
    Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
    Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-Based Differential Analysis to Identify Molecular Features of Tumorigenesis for Esophageal Squamous Carcinoma.
    Jiang S; Zhang Q; Su Y; Pan L
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29301256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between transmembrane serine protease expression and prognosis of esophageal squamous cell carcinoma.
    Liu GT; Shen C; Ren XH; Yang L; Yu YM; Xiu YX; Li RH; Jiang L; Zhang CL; Li YW
    J Biol Regul Homeost Agents; 2017; 31(4):1067-1072. PubMed ID: 29254316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma.
    Zhu Q; Huang L; Yang Q; Ao Z; Yang R; Krzesniak J; Lou D; Hu L; Dai X; Guo F; Liu F
    Nanoscale; 2021 Oct; 13(39):16457-16464. PubMed ID: 34648610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.
    Mei LL; Qiu YT; Zhang B; Shi ZZ
    Cancer Biomark; 2017; 19(1):1-9. PubMed ID: 28269750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data mining and bioinformatics of the expression data of esophageal squamous cell carcinoma.
    Sun Y; Li X; Jiang C; Xiao M; Zheng Y; Zhang J; Bu J
    Cell Biochem Biophys; 2014 Jul; 69(3):481-5. PubMed ID: 24595844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis.
    Wang X; Lai M; Wang Y; Chai R; Li N; Ou L; Zheng K; Li J; Xu G; Wang S; Dong Y; Wang S
    Biomed Res Int; 2022; 2022():3758731. PubMed ID: 35496042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
    Wang Y; Fang Q; Tian L; Yuan Z; Tian L; Zhou Z
    Technol Cancer Res Treat; 2020; 19():1533033820920967. PubMed ID: 32356485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.